(S (NP (DT This) (NN study)) (VP (VBZ presents) (NP (NP (DT a) (JJ new) (NN approach)) (SBAR (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (NP (JJ asymptomatic) (NNS carriers)) (PP (IN of) (NP (DT the) (NNP SARS-CoV-2) (NN virus)))))) (PP (IN by) (S (VP (VBG using) (NP (NP (NP (JJ interaction-based) (JJ continuous) (NN learning)) (CC and) (NP (NP (NN inference)) (PP (IN of) (NP (JJ individual) (NN probability))))) (PRN (-LRB- -LRB-) (NP (NNP CLIIP)) (-RRB- -RRB-))) (PP (IN for) (NP (JJ contagious) (NN ranking)))))))))))) (. .))
(S (NP (DT This) (NN approach)) (VP (VBZ is) (VP (VBN developed) (PP (VBN based) (PP (IN on) (NP (NP (DT an) (NN individual) (VBD directed) (NN graph)) (PRN (-LRB- -LRB-) (NP (NNP IDG)) (-RRB- -RRB-))))) (, ,) (S (VP (VBG using) (NP (NP (JJ multi-layer) (JJ bidirectional) (NN path) (NN tracking)) (CC and) (NP (NN inference) (NN searching))))))) (. .))
(S (NP (DT The) (NNP IDG)) (VP (VBZ is) (VP (VBN determined) (PP (IN by) (NP (NP (DT the) (NN appearance) (NN timeline)) (CC and) (NP (NP (JJ spatial) (NNS data)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB adapt) (PP (IN over) (NP (NN time)))))))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP (DT the) (NN approach)) (VP (VBZ takes) (PP (IN into) (NP (NN consideration))) (NP (NP (DT the) (NN incubation) (NN period)) (CC and) (NP (NP (JJ several) (NNS features)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB represent) (NP (JJ real-world) (NNS circumstances)))))) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ asymptomatic) (NNS carriers))) (ADJP (JJ present))))))) (. .))
(S (PP (IN After) (NP (NP (DT each) (NN update)) (PP (IN of) (NP (JJ confirmed) (NNS cases))))) (, ,) (NP (DT the) (NN model)) (VP (VP (VBZ collects) (NP (DT the) (NN interaction) (NNS features))) (CC and) (VP (NNS infers) (NP (NP (NP (DT the) (JJ individual) (NN person) (POS 's)) (NN probability)) (PP (IN of) (S (VP (VBG getting) (VP (VBN infected)))))) (S (VP (VBG using) (NP (NP (DT the) (NN status)) (PP (IN of) (NP (DT the) (VBG surrounding) (NNS people)))))))) (. .))
(S (NP (DT The) (NNP CLIIP) (NN approach)) (VP (VBZ is) (VP (VBN validated) (S (VP (VBG using) (NP (DT the) (JJ individualized) (JJ bidirectional) (NNP SEIR) (NN model)) (S (VP (TO to) (VP (VB simulate) (NP (DT the) (NN contagion) (NN process))))))))) (. .))
(S (PP (VBN Compared) (PP (TO to) (NP (JJ traditional) (NN contact) (VBG tracing) (NNS methods)))) (, ,) (NP (PRP$ our) (NN approach)) (VP (ADVP (RB significantly)) (VBZ reduces) (NP (NP (DT the) (NN screening) (CC and) (NN quarantine)) (VP (VBN required) (S (VP (TO to) (VP (VB search) (PP (IN for) (NP (DT the) (JJ potential) (JJ asymptomatic) (NN virus) (NNS carriers)))))))) (PP (IN by) (NP (QP (RB as) (JJ much) (IN as) (CD 94)) (NN %)))) (. .))
